At Home Treatment of COPD Exacerbation
Links shared publicly online about this topic
Antibiotics cut COPD exacerbations | GPonline.com
gponline.com — “Antibiotic treatment of COPD with azithromycin reduces exacerbations by a quarter, but may affect some patients‘ hearing, a US study suggests.” View full resource at gponline.com
Most Recently Shared on September 8, 2011 at 8:21 am By:
Dr Mark S. Bonar Doctor and Physician
Antibiotics cut COPD exacerbations http://t.co/kV3z6Gi
Azithromycin can effectively reduce acute COPD exacerbations
news-medical.net — “A common antibiotic added to the usual treatment plan for some patients with chronic obstructive pulmonary disease can reduce acute exacerbations — sudden onsets of worsened cough, wheezing and labored breathing — and improve quality of life, according to findings from the COPD Clinical Research Network reported in the Aug. 25, 2011, issue of the New England Journal of Medicine.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 5:58 am By:
Stroke News: Azithromycin can effectively reduce acute COPD exacerbations: A common antibiotic added to the us... http://t.co/jVpqnYq
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
drugs.com — “Spiriva HandiHaler (tiotropium bromide) is used for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Includes Spiriva HandiHaler side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 20, 2009 at 7:35 pm By:
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - http://bit.ly/8NzjMW
Early Spiriva Treatment Slows COPD
webmd.com — “Spiriva, begun early in the course of COPD, slows loss of lung function, decreases disease exacerbations, and likely extends survival, a large clinical trial shows.” View full resource at webmd.com
Most Recently Shared on August 27, 2009 at 10:45 pm By:
Early COPD Treatment Slows Disease: Spiriva, begun early in the course of COPD, slows loss of lung function, dec.. http://bit.ly/S38fn
COPD: Is There a Frequent-Exacerbation Phenotype? - QualityPoint Technologies
qualitypointtech.net — “A study suggests the rate at which exacerbations occur in COPD may constitute a distinct phenotype, regardless of disease severity. How might treatment be affected? Dr. Andy Shorr offers perspective. Medscape Pulmonary Medicine” View full resource at qualitypointtech.net
Most Recently Shared on October 11, 2010 at 5:01 pm By:
COPD: Is There a Frequent-Exacerbation Phenotype?: A study suggests the rate at which exacerbations occur in COPD ... http://bit.ly/bNG1DI
Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations
news-medical.net — “Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations.” View full resource at news-medical.net
Most Recently Shared on January 21, 2010 at 12:05 pm By:
Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations: Chronic obstructive pulmonary dis... http://bit.ly/64eIqS
Tiotropium vs. Salmeterol for COPD Exacerbations - QualityPoint Technologies
qualitypointtech.net — “Both inhaled long-acting beta-agonists and inhaled anticholinergic agents are first-line treatments for patients with moderate-to-severe chronic obstructive pulmonary disease. Which is better? Journal Watch” View full resource at qualitypointtech.net
Most Recently Shared on April 13, 2011 at 10:35 am By:
Tiotropium vs. Salmeterol for COPD Exacerbations: Both inhaled long-acting beta-agonists and inhaled anticholinerg... http://bit.ly/ffaGpD
Forest Announces FDA Approval of DalirespTM (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients with Severe COPD Associated with Chronic Bronchitis and a History of Exacerbations - News Press Release | PharmiWeb.com
pharmiweb.com — “Forest Announces FDA Approval of DalirespTM (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients with Severe COPD Associated with Chronic Bronchitis and a History of Exacerbations - News Press Release | PharmiWeb.com” View full resource at pharmiweb.com
Most Recently Shared on March 1, 2011 at 2:06 pm By:
Press Release: Forest Laboratories Inc. Posted on:01 Mar 11 Forest Laboratories, Inc. (NYSE: FRX) announced toda... http://bit.ly/eOv2Mj
Promising Results Of Roflumilast Treatment For Some Patients With COPD
medicalnewstoday.com — “Two articles published in this week's copd special edition of the lancet report that the drug roflumilast improves lung function and reduces exacerbations in patients with chronic obstructi” View full resource at medicalnewstoday.com
Most Recently Shared on August 28, 2009 at 10:29 am By:
Promising Results Of Roflumilast Treatment For Some Patients With COPD: Two articles published in this week's CO.. http://bit.ly/7jkh0
Early treatment linked to better COPD outcomes
ethiopianreview.com — “Among patients hospitalised for acute exacerbations of chronic obstructive pulmonary disease (COPD), those who received antibiotics in the first two hospital” View full resource at ethiopianreview.com
Most Recently Shared on June 16, 2010 at 8:41 pm By:
Rick Frea Patient Expert and Health Professional
Quick antibiotic therapy = quicker discharge times for COPD patients: http://www.ethiopianreview.com/news/147395
Daliresp Available for COPD - ONA
oncologynurseadvisor.com — “Forest announced that beginning mid-June 2011, Daliresp (roflumilast tablets) will be available as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.” View full resource at oncologynurseadvisor.com
Most Recently Shared on June 10, 2011 at 1:48 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Daliresp Available for COPD http://goo.gl/fb/uekbD
Daliresp Available for COPD - MPR
empr.com — “Forest announced that beginning mid-June 2011, Daliresp (roflumilast tablets) will be available as a treatment to reduce the risk of chronic obstructive pulmonary disease (COPD) exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.” View full resource at empr.com
Most Recently Shared on June 10, 2011 at 2:11 pm By:
MPR News: Daliresp Available for COPD: Forest announced that beginning mid-June 2011, Daliresp (roflumilast tabl... http://bit.ly/kzaEnN
Daliresp Approved for COPD - MPR
empr.com — “Forest announced that Daliresp (roflumilast tablets) has been approved as a treatment to reduce the risk of chronic obstructive pulmonary disease exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.” View full resource at empr.com
Most Recently Shared on March 1, 2011 at 4:46 pm By:
MPR News: Daliresp Approved for COPD: Forest announced that Daliresp (roflumilast tablets) has been approved as ... http://bit.ly/gUr3Eh
COPD Health Center -- WebMD
webmd.com — “WebMD--™s COPD Health Center provides in-depth information on chronic obstructive pulmonary disease including symptoms, causes, treatment options, diagnosis, and tests.” View full resource at webmd.com
Most Recently Shared on November 17, 2010 at 9:41 pm By:
World Chronic Obstructive Pulmonary Disease (COPD) Day is a global effort to help others understand the disease. http://bit.ly/aMmfNn
Entest BioMedical Files Patent Application On Chemokine Technology To Increase Efficacy Of Tissue-Specific Stem Cell Homing In COPD Treatment
medicalnewstoday.com — “Entest BioMedical Inc. (OTCBB: ENTB) announced the filing of a patent application covering the use of stem cell attracting molecules called chemokines in the treatment of Chronic Obstructive Pulm” View full resource at medicalnewstoday.com
Most Recently Shared on March 25, 2010 at 1:15 pm By:
Entest BioMedical Files Patent Application On Chemokine Technology To Increase Efficacy Of Tissue-Specific Stem Cell H... http://mnt.to/3zpL
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Dr Mark S. Bonar
Medical Doctor (NHS & Private GP), Entrepreneur, Epistemologist, Polymath, Political Activist, Notable Philanthropist, Technophile, Socialite.
-
News-Medical.Net
Stay up to date with the latest Stroke news and research via News-Medical.Net
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
